Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $92,637 | 53 | 62.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $44,318 | 28 | 29.8% |
| Travel and Lodging | $7,542 | 42 | 5.1% |
| Food and Beverage | $2,447 | 42 | 1.6% |
| Unspecified | $1,691 | 10 | 1.1% |
| Education | $78.15 | 4 | 0.1% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $42,674 | 63 | $0 (2023) |
| Insmed, Inc. | $41,708 | 45 | $0 (2023) |
| Chiesi USA, Inc. | $34,334 | 45 | $0 (2021) |
| PTC Therapeutics, Inc. | $6,400 | 2 | $0 (2018) |
| ABBVIE INC. | $6,050 | 6 | $0 (2023) |
| Mylan Specialty L.P. | $5,621 | 5 | $0 (2024) |
| Genentech, Inc. | $5,122 | 7 | $0 (2018) |
| Novartis Pharmaceuticals Corporation | $3,081 | 1 | $0 (2018) |
| Nabriva Therapeutics, plc | $2,203 | 1 | $0 (2021) |
| Merck Sharp & Dohme Corporation | $1,488 | 2 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $27.92 | 1 | Mylan Specialty L.P. ($27.92) |
| 2023 | $20,657 | 25 | Insmed, Inc. ($9,465) |
| 2022 | $35,958 | 23 | Insmed, Inc. ($26,958) |
| 2021 | $11,611 | 10 | Vertex Pharmaceuticals Incorporated ($3,500) |
| 2020 | $2,507 | 6 | Insmed, Inc. ($2,030) |
| 2019 | $11,348 | 24 | Chiesi USA, Inc. ($11,317) |
| 2018 | $41,083 | 59 | Vertex Pharmaceuticals Incorporated ($17,279) |
| 2017 | $25,519 | 31 | VERTEX PHARMACEUTICALS INCORPORATED ($10,681) |
All Payment Transactions
179 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/20/2024 | Mylan Specialty L.P. | TOBI PODHALER (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: Aminoglycosides | ||||||
| 12/13/2023 | Vertex Pharmaceuticals Incorporated | — | Consulting Fee | Cash or cash equivalent | $4,691.25 | General |
| 09/18/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 09/18/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $375.00 | General |
| 08/18/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $707.00 | General |
| 07/13/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $208.35 | General |
| 06/08/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 04/12/2023 | Insmed, Inc. | — | — | Cash or cash equivalent | $250.00 | Research |
| 04/12/2023 | Insmed, Inc. | — | — | Cash or cash equivalent | $225.00 | Research |
| 04/12/2023 | Insmed, Inc. | — | — | Cash or cash equivalent | $125.00 | Research |
| 04/12/2023 | Insmed, Inc. | — | — | Cash or cash equivalent | $125.00 | Research |
| 04/12/2023 | Insmed, Inc. | — | — | Cash or cash equivalent | $80.00 | Research |
| 04/12/2023 | Insmed, Inc. | — | — | Cash or cash equivalent | $75.00 | Research |
| 02/09/2023 | Mylan Specialty L.P. | — | Consulting Fee | Cash or cash equivalent | $3,000.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $170.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $170.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $165.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $165.00 | General |
| 02/06/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $125.00 | General |
| 01/05/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,500.00 | General |
| 01/05/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/05/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| 01/05/2023 | Insmed, Inc. | — | Consulting Fee | Cash or cash equivalent | $500.00 | General |
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| Epidemiologic Study of Cystic Fibrosis ICON Protocol 130-044 Statistical analysis of data previously obtained from a multicenter, longitudinal study Study IDZ0595n of patients with cystic fibrosis | Genentech, Inc. | $696.54 | 1 |
| Statistical analysis of data previously obtained from a multicenter, longitudinal study Study IDZ0595n of patients with cystic fibrosis. | Genentech, Inc. | $114.00 | 3 |
About Dr. Michael Konstan, MD
Dr. Michael Konstan, MD is a Pediatric Pulmonology healthcare provider based in Cleveland, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568482537.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Konstan, MD has received a total of $148,712 in payments from pharmaceutical and medical device companies, with $27.92 received in 2024. These payments were reported across 179 transactions from 12 companies. The most common payment nature is "Consulting Fee" ($92,637).
Practice Information
- Specialty Pediatric Pulmonology
- Location Cleveland, OH
- Active Since 07/20/2006
- Last Updated 11/17/2010
- Taxonomy Code 2080P0214X
- Entity Type Individual
- NPI Number 1568482537
Products in Payments
- PERTZYE (Drug) $30,385
- SYMDEKO (Drug) $17,243
- BETHKIS (Drug) $3,927
- ORKAMBI (Drug) $3,552
- TOBI PODHALER (Drug) $3,109
- Arikayce (Drug) $2,750
- ZERBAXA (Drug) $1,488
- Non-Covered Product (Drug) $696.54
- Pulmozyme (Biological) $114.00
- TOBI Podhaler (Drug) $97.42
- Creon (Drug) $31.13
- ZENPEP (Drug) $30.22
- BRONCHITOL (Drug) $23.16
- CREON (Drug) $19.03
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Pulmonology Doctors in Cleveland
Dr. John Carl, Md, MD
Pediatric Pulmonology — Payments: $3,589
Daniel Craven, Md, MD
Pediatric Pulmonology — Payments: $446.11
Carol Rosen, Md, MD
Pediatric Pulmonology — Payments: $133.73
Robert Stern, Md, MD
Pediatric Pulmonology — Payments: $102.16
Pamela Davis, Md, MD
Pediatric Pulmonology — Payments: $29.61
Laura Milgram, Md, MD
Pediatric Pulmonology — Payments: $19.99